Vaishali Pharma wins new order worth Rs 32 crore for PPE kits; share zooms 5 per cent
On Thursday, Vaishali Pharma announced that it has recorded yet another bulk order worth Rs 32 crore pertaining to the supply of the pharma & consumable products such as PPE kits, which forms a part of the COVID-19 medical kit.
Vaishali Pharma informed the shareholders that they had implemented planned marketing strategies, having base of the firm's efforts.
Vaishali Pharma is also expecting approvals from international markets towards more opportunities in future. The company strives to reach maximum people with good quality medical products at affordable prices. The company is also predicting accelerated growth along with better quarterly performance and also pocketing some good opportunities in domestic and international markets.
Vaishali Pharma has its headquarters in Mumbai and deals in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements as well as herbal and nutraceutical products in domestic & export markets.
Reacting to this news, the stock of Vaishali Pharma was trading at Rs 52.55, up by 5 per cent on NSE in the second half of the trading session.